Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

510(k) Premarket Notification
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back To Search Results
Device Classification Name system, mass spectrometry, multiplex genotyping, hereditary thrombophilia related mutations
510(k) Number K132978
Device Name IMPACT DX FACTOR V LEIDEN AND FACTOR II GENOTYPING TEST
Applicant
SEQUENOM, INC.
3595 JOHN HOPKINS COURT
SAN DIEGO,  CA  92121
Applicant Contact Robin Weiner
Correspondent
SEQUENOM, INC.
3595 JOHN HOPKINS COURT
SAN DIEGO,  CA  92121
Correspondent Contact Robin Weiner
Regulation Number864.7280
Classification Product Code
PHJ  
Date Received09/23/2013
Decision Date 06/13/2014
Decision Substantially Equivalent (SESE)
Regulation Medical Specialty Hematology
510k Review Panel Pathology
Summary Summary
FDA Review Decision Summary
Type Traditional
Reviewed by Third Party No
Combination Product No
-
-